Document Detail


Proposal of a multicompartmental model for use in the study of apolipoprotein E metabolism.
MedLine Citation:
PMID:  9711986     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Apolipoprotein (apo) E is a 299-amino acid glycoprotein that serves a number of functions in lipoprotein metabolism. Apo E binds to the triglyceride-rich lipoproteins (TRL), very-low-density lipoprotein (VLDL), and chylomicrons, as they are lipolyzed, mediating their removal from plasma via lipoprotein receptors. Apo E is also found associated with high-density lipoprotein (HDL) and has been suggested to play a role in reverse cholesterol transport. Studies on the kinetic behavior of apo E from the TRL and HDL fractions provide insights into the metabolic relationships between TRL and HDL in vivo. We sought to develop a compartmental model that can be used for analysis of kinetic data in studies on the metabolism of TRL and HDL apo E. Using radioactive tracers, it has been previously observed that, in some instances, a portion of VLDL apo E that is removed from plasma subsequently reappears in VLDL. Four multicompartmental models were considered that could account for this type of behavior: model A, in which there is transfer of apo E from HDL to VLDL; model B, in which there is a bidirectional extravascular exchange; model C, in which there is removal and subsequent reintroduction of TRL apo E into plasma; and model D, in which there is secretion of TRL apo E into plasma directly and via an extravascular pathway. Models C and D provided the best fit to the experimental data. While no physiologically plausible analog to model C could be found, an extravascular delay, analogous to newly secreted apo E that enters the lymphatic system before appearing in plasma, was postulated for model D. It was this model that was used to analyze kinetic data from metabolic studies of apo E. The model was able to provide a satisfactory fit to kinetic data in studies in which subjects were given a primed-constant infusion of 2H3-leucine. It was determined that TRL apo E from the six subjects studied had a mean residence time of 0.11 +/- 0.05 days and a mean production rate of 10.6 +/- 7.2 mg/kg/d, while HDL apo E had a mean residence time of 2.96 +/- 0.99 days and a mean production rate of 0.07 +/- 0.07 mg/kg/d. We conclude that this model describes a potential pathway for the metabolism of a portion of apo E in plasma and can be used to calculate the residence time and production rate of TRL and HDL apo E under a variety of conditions.
Authors:
J S Millar; A H Lichtenstein; G G Dolnikowski; J M Ordovas; E J Schaefer
Related Documents :
2751746 - Apolipoproteins c-ii and c-iii metabolism in hypertriglyceridemic patients. effect of a...
2305026 - Changes in plasma lipids and dietary intake accompanying shifts in perceived workload a...
16455106 - Apolipoprotein a-i/apolipoprotein b ratio and aggression in violent and nonviolent youn...
7554296 - Relationships between triglycerides, lipoproteins, glucose and coronary artery disease.
17513436 - Unique aspects of lysine nutrition and metabolism.
8056656 - Prepartum body condition and weight influences on reproductive performance of first-cal...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Metabolism: clinical and experimental     Volume:  47     ISSN:  0026-0495     ISO Abbreviation:  Metab. Clin. Exp.     Publication Date:  1998 Aug 
Date Detail:
Created Date:  1998-08-28     Completed Date:  1998-08-28     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0375267     Medline TA:  Metabolism     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  922-8     Citation Subset:  IM    
Affiliation:
Lipid Metabolism Laboratory, Jean Mayer US Department of Agriculture, Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Apolipoproteins E / biosynthesis,  blood,  metabolism*
Cholesterol, HDL / biosynthesis,  blood,  metabolism*
Humans
Kinetics
Lipids / blood
Male
Middle Aged
Phenotype
Triglycerides / biosynthesis,  blood,  metabolism*
Grant Support
ID/Acronym/Agency:
HL-39326/HL/NHLBI NIH HHS; T32-AG000209/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Apolipoproteins E; 0/Cholesterol, HDL; 0/Lipids; 0/Triglycerides

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and coul...
Next Document:  Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obe...